New gene therapy in Korea on the progress.

A gene therapeutic possibility showed quite a promising prospect by the local pharmaceutical industries including Dong-A, Yuhan and Kolon and the bio venture companies such as Biromed and Newgenepharm.

Biromed and Dong-A jointly developed an ischemic foot ulcer therapy, which is now on the phase II clinical studies at Seoul Samsung hospital and Yonsei Univ. Severance hospital. When the st...